2017
DOI: 10.1155/2017/2841682
|View full text |Cite
|
Sign up to set email alerts
|

Preparation of a Microporous Polyurethane Film with Negative Surface Charge for siRNA Delivery via Stent

Abstract: Polyurethane (PU) and polyethylene glycol (PEG) were used to prepare a porous stent-covering material for the controlled delivery of small interfering RNA (siRNA). Microporous polymer films were prepared using a blend of polyurethane and water-soluble polyethylene glycol by the solution casting method; the PEG component was extracted in water to make the film microporous. This film was dipped in 2% poly(methyl methacrylate-co-methacrylic acid) solution to coat the polymer film with the anionic polyelectrolyte.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 22 publications
1
2
0
Order By: Relevance
“…The spectrum of pure 5FU exhibited characteristic peaks at ~2940, 1740, 1250 and 1230 cm −1 consistent with C–H, C=O, C–N and C–F stretching vibrations, respectively, and at ~825 cm −1 consistent with C-H deformation [ 32 , 59 , 60 , 61 ]. For PU coatings (drug-free), the spectrum revealed peaks at ~3330, 2930, 1740 and 1270 cm −1 corresponding to N–H, C–H, C=O and C–O stretching vibrations, and consistent with the reported aliphatic polycarbonate-PU structure [ 62 , 63 , 64 , 65 ]. In comparison, the spectrum of the PU 5FU coating (basecoat) included all of the characteristic peaks of the PU with a slight broadening of peaks at ~1280 and 814 cm −1 due to the presence of 5FU, indicating its successful inclusion into the PU matrix without any apparent changes in their corresponding chemical structures.…”
Section: Resultssupporting
confidence: 80%
“…The spectrum of pure 5FU exhibited characteristic peaks at ~2940, 1740, 1250 and 1230 cm −1 consistent with C–H, C=O, C–N and C–F stretching vibrations, respectively, and at ~825 cm −1 consistent with C-H deformation [ 32 , 59 , 60 , 61 ]. For PU coatings (drug-free), the spectrum revealed peaks at ~3330, 2930, 1740 and 1270 cm −1 corresponding to N–H, C–H, C=O and C–O stretching vibrations, and consistent with the reported aliphatic polycarbonate-PU structure [ 62 , 63 , 64 , 65 ]. In comparison, the spectrum of the PU 5FU coating (basecoat) included all of the characteristic peaks of the PU with a slight broadening of peaks at ~1280 and 814 cm −1 due to the presence of 5FU, indicating its successful inclusion into the PU matrix without any apparent changes in their corresponding chemical structures.…”
Section: Resultssupporting
confidence: 80%
“…Many new molecules also hold promise for improving future drug-eluting stent designs. The possibility of delivering small-interfering ribonucleic acid (siRNA delivery) is currently being investigated ( Hossfeld et al, 2013 ; Che et al, 2016 ; Cho and Park, 2017 ). siRNA are short double-stranded RNA molecules that interfere with the expression of specific genes.…”
Section: Localized Drug Delivery From Vascular Stentsmentioning
confidence: 99%
“…Many new molecules have appeared on the scene for possible use and promise to improve future drug-eluting stent models. Among these, very promising and under current investigation are the gene-eluting stents that can provide small interfering ribonucleic acid with siRNA release [ 68 , 107 , 108 ]. In this way, the stents that make use of embedded siRNA (RNA molecules impeding target gene expression) have as their objective a modulating effect on the receptors of the adhesion molecules to reduce thrombosis and inflammation [ 68 ] or to suppress the proliferation of SMCs, useful for preventing restenosis [ 85 ].…”
Section: Future Direction For the Stent Designmentioning
confidence: 99%